Executive Series - Bionomics Ltd (BNO) CEO & MD, Dr Deborah Rathjen

CommSec
Online Stockbroker
CommSec’s Tom Piotrowski speaks with Bionomics Ltd (BNO) CEO & MD, Dr Deborah Rathjen about the company’s newly signed deals with Merck, its new anxiety drug trial and its cancer treatment trials To view more Executive Series interviews, visit: (VIEW LINK)
3 topics

CommSec
Online Stockbroker
Online Stockbroker
CommSec is Australia's leading online broker. CommSec has been committed to providing the best in online trading since 1995. CommSec helps make informed investment decisions with comprehensive market research, free live pricing and powerful...
Expertise
No areas of expertise
most popular
Equities
6 stocks for a full portfolio reset in 2023
Livewire Markets
Equities
What worked in equity markets in 2022
Aoris Investment Management
Please sign in to comment on this wire.